Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Laurent Chanroux
  • May 26, 2015
  • Articles

Arthritis Awareness Month, May 2015

Arthritis Awareness Month, May 2015

May marks arthritis awareness month, in which many non-profits, advocates, and experts from around the world unite to take part in a drive to raise awareness of the disease and the issues involved.

Arthritis is an umbrella term used to describe over 100 medical conditions and diseases, known as rheumatic diseases. Arthritis is an inflammation of the joints which causes most people to experience pain and difficulty moving around, some of whom are unable to work due to symptoms being too severe. Two of the most common forms of arthritis are osteoarthritis and rheumatoid arthritis.

read more »

  • Posted by Rachel Howard
  • May 20, 2015
  • Articles

Spotlight on Saudi Arabia

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard

What are the opportunities and challenges for pharma companies wishing to gain a foothold in this oil-rich kingdom?
Traditionally the Middle East and North Africa (MENA) region has been overlooked by pharmaceutical companies, with the region contributing only about 2% of global pharmaceutical sales in 2010. Difficult regulatory environments and political turmoil have compounded the perceived lack of attractiveness of the region as a whole.
 
 

read more »

"This is incredibly insightful..."

"This is incredibly insightful and a powerful body of work."
Head of Global Patient Experience

read more »

North Asia infographic

North Asia infographic

North Asia's largest markets; China, Hong Kong, Japan, South Korea and Taiwan, are home to more than 1.6 billion people and is a key global growth region. With pharmaceutical sales of more than $215bn, it is an attractive region for pharma, however one in which each market differs in terms of opportunities and challenges.

read more »